INFLIXIMAB
NDC 57894-160, INFLIXIMAB, injection, powder, lyophilized, for solution, from Janssen Biotech, Inc..
- Product NDC
- 57894-160
- Status
- Listed
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103772
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57894-160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INFLIXIMAB100 mg/10mL
Pharmacologic classes
Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57894-160-01 | 57894016001 | 1 VIAL, SINGLE-USE in 1 BOX (57894-160-01) / 10 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b05c174f-832c-4321-b34f-2c4ad3742269Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=57894-160
Use it
Look up 57894-160 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57894-160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57894-160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.